Matthew Wein, See Remarks at Metagenomi Therapeutics, Inc. (MGX), sold 482 shares at $1.60 ($771) on 2026-03-05, disclosed to the SEC on 2026-03-09.
Open-market sale of $771 MGX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MGX | SELL | 2025-12-08 | $352 | — | Filing → |
| MGX | SELL | 2025-12-01 | $360 | — | Filing → |
| MGX | SELL | 2025-06-09 | $348 | — | Filing → |